• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸段SMARCA4缺陷型未分化肿瘤和SMARCA4缺陷型非小细胞肺癌的细针穿刺及积液细胞学检查:27例患者的多机构经验

Fine-needle aspiration and effusion cytology of thoracic SMARCA4-deficient undifferentiated tumor and SMARCA4-deficient non-small cell lung carcinoma: A multi-institutional experience with 27 patients.

作者信息

Zalles Nicole, Mukhopadhyay Sanjay, Satturwar Swati, Lajara Sigfred, Khader Samer, Pantanowitz Liron, Elsheikh Tarik M

机构信息

Department of Pathology, Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Department of Pathology, The Ohio State University, Columbus, Ohio, USA.

出版信息

Cancer Cytopathol. 2025 Jan;133(1):e22919. doi: 10.1002/cncy.22919. Epub 2024 Nov 18.

DOI:10.1002/cncy.22919
PMID:39555952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695706/
Abstract

BACKGROUND

Thoracic switch/sucrose nonfermentable-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4)-deficient (SD) malignancies, including SD undifferentiated tumor (SD-UT) and SD non-small cell lung carcinoma (SD-NSCLC), have been recently described. The cytologic features of these neoplasms in fine-needle aspiration (FNA) and effusion specimens have rarely been reported in the literature. This study aimed to describe and compare the spectrum of cytologic, immunohistochemical, and clinical features of these high-grade malignancies recently encountered at the participating institutions.

METHODS

This study documented clinical and imaging characteristics of tumors from 27 patients. Sixteen cytomorphologic features and immunohistochemical findings were compared between SD-UT and SD-NSCLC samples.

RESULTS

Twenty three FNAs, two bronchial brushings, and two pleural fluids were evaluated, including 17 SD-UT cases (mean patient age, 70 years) and 10 SD-NSCLC cases (mean patient age, 62 years). Both malignancies presented with large thoracic masses and/or hilar/mediastinal lymphadenopathy. All SD-UT cytologic samples had a discohesive or mixed cohesive-discohesive architecture, and most (13 of 17) showed predominant rhabdoid or mixed rhabdoid-epithelioid features. Most SD-NSCLC cytologic samples (nine of 10) were either cohesive or mixed cohesive-discohesive and had a predominantly epithelioid morphology (eight of 10). Keratins and claudin-4 were negative or focally positive in SD-UT samples, whereas they were diffusely positive in SD-NSCLC samples. Both malignancies were negative for TTF-1 and p40/p63 and showed loss of expression of SMARCA4.

CONCLUSIONS

Although there is considerable clinical and cytopathologic overlap between SD-UT and SD-NSCLC, some key features allow for their distinction. SD-UT is mostly discohesive with rhabdoid or mixed rhabdoid-epithelioid features, whereas SD-NSCLC often has cohesive epithelioid morphology. The combination of clinical presentation, cytomorphology, and immunohistochemistry is essential for a definitive diagnosis.

摘要

背景

胸段开关/蔗糖非发酵相关、基质相关、肌动蛋白依赖性染色质调节因子A亚家族成员4(SMARCA4)缺陷(SD)恶性肿瘤,包括SD未分化肿瘤(SD-UT)和SD非小细胞肺癌(SD-NSCLC),最近已被描述。这些肿瘤在细针穿刺(FNA)和积液标本中的细胞学特征在文献中鲜有报道。本研究旨在描述和比较参与机构近期遇到的这些高级别恶性肿瘤的细胞学、免疫组织化学和临床特征谱。

方法

本研究记录了27例患者肿瘤的临床和影像学特征。比较了SD-UT和SD-NSCLC样本的16种细胞形态学特征和免疫组织化学结果。

结果

评估了23份FNA、2份支气管刷检和2份胸腔积液样本,包括17例SD-UT病例(患者平均年龄70岁)和10例SD-NSCLC病例(患者平均年龄62岁)。两种恶性肿瘤均表现为胸部巨大肿块和/或肺门/纵隔淋巴结肿大。所有SD-UT细胞学样本均具有松散或混合的紧密-松散结构,且大多数(17例中的13例)表现出主要的横纹肌样或混合的横纹肌样-上皮样特征。大多数SD-NSCLC细胞学样本(10例中的9例)为紧密或混合的紧密-松散结构,且主要具有上皮样形态(10例中的8例)。细胞角蛋白和claudin-4在SD-UT样本中为阴性或局灶性阳性,而在SD-NSCLC样本中为弥漫性阳性。两种恶性肿瘤的TTF-1和p40/p63均为阴性,并显示SMARCA4表达缺失。

结论

尽管SD-UT和SD-NSCLC之间存在相当大的临床和细胞病理学重叠,但一些关键特征有助于区分它们。SD-UT大多为松散结构,具有横纹肌样或混合的横纹肌样-上皮样特征,而SD-NSCLC通常具有紧密的上皮样形态。临床表现、细胞形态学和免疫组织化学的结合对于明确诊断至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/3ea6ff83fc30/CNCY-133-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/973c7afe0679/CNCY-133-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/a89b808e4008/CNCY-133-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/3dadf0af2e4c/CNCY-133-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/b3300fa0f0bc/CNCY-133-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/1d5d922c6662/CNCY-133-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/66fb94a36b6e/CNCY-133-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/c70eff687678/CNCY-133-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/a203b2748681/CNCY-133-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/3ea6ff83fc30/CNCY-133-0-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/973c7afe0679/CNCY-133-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/a89b808e4008/CNCY-133-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/3dadf0af2e4c/CNCY-133-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/b3300fa0f0bc/CNCY-133-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/1d5d922c6662/CNCY-133-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/66fb94a36b6e/CNCY-133-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/c70eff687678/CNCY-133-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/a203b2748681/CNCY-133-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49dc/11695706/3ea6ff83fc30/CNCY-133-0-g007.jpg

相似文献

1
Fine-needle aspiration and effusion cytology of thoracic SMARCA4-deficient undifferentiated tumor and SMARCA4-deficient non-small cell lung carcinoma: A multi-institutional experience with 27 patients.胸段SMARCA4缺陷型未分化肿瘤和SMARCA4缺陷型非小细胞肺癌的细针穿刺及积液细胞学检查:27例患者的多机构经验
Cancer Cytopathol. 2025 Jan;133(1):e22919. doi: 10.1002/cncy.22919. Epub 2024 Nov 18.
2
Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma.SMARCA4(BRG1)缺陷型非小细胞肺癌的细胞形态学和免疫表型分析。
J Am Soc Cytopathol. 2022 Jul-Aug;11(4):183-193. doi: 10.1016/j.jasc.2022.04.001. Epub 2022 Apr 6.
3
Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.SMARCA4 缺陷性胸内肿瘤的细胞学:SMARCA4 缺陷性非小细胞肺癌与 SMARCA4 缺陷性胸内肉瘤的比较分析。
Acta Cytol. 2021;65(1):67-74. doi: 10.1159/000510323. Epub 2020 Aug 27.
4
Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.胸段SMARCA4缺陷型肿瘤:52例SMARCA4缺陷型非小细胞肺癌及20例胸段SMARCA4缺陷型未分化肿瘤的临床病理分析
PeerJ. 2024 Feb 16;12:e16923. doi: 10.7717/peerj.16923. eCollection 2024.
5
Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.诊断细胞学中胸 SMARCA4 缺陷型未分化肿瘤。
Cancer Cytopathol. 2023 Aug;131(8):526-534. doi: 10.1002/cncy.22709. Epub 2023 Jun 6.
6
Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.胸部 SMARCA4 缺陷型未分化肿瘤的最新进展。
Semin Diagn Pathol. 2021 Sep;38(5):83-89. doi: 10.1053/j.semdp.2021.06.001. Epub 2021 Jun 4.
7
Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report.细胞块检查在胸部分化不良 SMARCA4 缺陷性肿瘤的细胞学诊断中的应用:一例报告。
Diagn Cytopathol. 2023 May;51(5):E149-E154. doi: 10.1002/dc.25116. Epub 2023 Feb 11.
8
Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features.SMARCA4 缺陷型非小细胞肺癌的细胞形态学特征及其与免疫组织化学和分子特征的相关性。
Cancer Cytopathol. 2022 Aug;130(8):620-629. doi: 10.1002/cncy.22581. Epub 2022 Apr 25.
9
Thoracic SMARCA4-Deficient Undifferentiated Tumors With Unusual Presentations: A Case Series.胸内 SMARCA4 缺陷未分化肿瘤的异常表现:病例系列研究。
Int J Surg Pathol. 2024 Aug;32(5):992-998. doi: 10.1177/10668969231206350. Epub 2023 Oct 30.
10
Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.伴有神经节神经瘤和内生软骨瘤的胸椎SMARCA4缺陷未分化肿瘤:对SLC7A11和ARID1A表达的影响:一例报告
Diagn Pathol. 2022 Feb 12;17(1):29. doi: 10.1186/s13000-022-01205-8.

本文引用的文献

1
CIC-Rearranged Sarcoma.CIC 重排肉瘤。
Surg Pathol Clin. 2024 Mar;17(1):141-151. doi: 10.1016/j.path.2023.06.003. Epub 2023 Aug 1.
2
Cytopathologic diagnosis of extragonadal germ cell tumors: A 10-year institutional review.性腺外生殖细胞肿瘤的细胞病理学诊断:一项为期10年的机构回顾。
Cancer Cytopathol. 2023 Dec;131(12):791-799. doi: 10.1002/cncy.22761. Epub 2023 Sep 25.
3
Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.诊断细胞学中胸 SMARCA4 缺陷型未分化肿瘤。
Cancer Cytopathol. 2023 Aug;131(8):526-534. doi: 10.1002/cncy.22709. Epub 2023 Jun 6.
4
Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma.SMARCA4(BRG1)缺陷型非小细胞肺癌的细胞形态学和免疫表型分析。
J Am Soc Cytopathol. 2022 Jul-Aug;11(4):183-193. doi: 10.1016/j.jasc.2022.04.001. Epub 2022 Apr 6.
5
Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features.SMARCA4 缺陷型非小细胞肺癌的细胞形态学特征及其与免疫组织化学和分子特征的相关性。
Cancer Cytopathol. 2022 Aug;130(8):620-629. doi: 10.1002/cncy.22581. Epub 2022 Apr 25.
6
Thoracic SMARCA4-deficient undifferentiated tumor-a case of an aggressive neoplasm-case report.胸段SMARCA4缺陷型未分化肿瘤——一例侵袭性肿瘤病例报告
Mediastinum. 2021 Dec 25;5:39. doi: 10.21037/med-20-15. eCollection 2021.
7
Cytology of Undifferentiated Round-Cell Sarcomas of Bone and Soft Tissue: Ewing Sarcoma or Not Ewing Sarcoma, That Is the Question.骨和软组织未分化小圆细胞肉瘤的细胞学:尤文肉瘤还是非尤文肉瘤,这是个问题。
Acta Cytol. 2022;66(4):295-306. doi: 10.1159/000518146. Epub 2021 Aug 25.
8
Can cytology reliably subtype non-small cell lung carcinomas?细胞学能否可靠地下非小细胞肺癌的亚型?
Cytopathology. 2022 Jan;33(1):8-13. doi: 10.1111/cyt.13056. Epub 2021 Sep 21.
9
SMARCA4-Deficient Undifferentiated Tumor Diagnosed on Adrenal Sampling.SMARCA4 缺陷未分化肿瘤经肾上腺取样诊断。
Am J Clin Pathol. 2022 Jan 6;157(1):140-145. doi: 10.1093/ajcp/aqab101.
10
Perspectives and Issues in the Assessment of Deficiency in the Management of Lung Cancer Patients.肺癌患者管理中不足的评估的观点和问题。
Cells. 2021 Jul 29;10(8):1920. doi: 10.3390/cells10081920.